ACASTI PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.85 USD | +2.52% |
|
-1.72% | -1.38% |
| Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
| Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 3.050 | 3.450 | 3.450 |
| Spread/Res. | -6.55% | -17.39% | -17.39% |
| Spread/Supp. | +6.35% | +11.77% | +61.02% |
| Support | 2.680 | 2.550 | 1.770 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ACST Stock
- Charts Acasti Pharma Inc.
